Currently out of the existing stock ratings of David Stanton, 10 are a HOLD (50%), 9 are a BUY (45%), 1 are a SELL (5%).

David Stanton

Work Performance Price Targets & Ratings Chart

Analyst David Stanton, currently employed at JEFFERIES, carries an average stock price target met ratio of 50% that have a potential upside of 24.31% achieved within 184 days.

David Stanton’s has documented 34 price targets and ratings displayed on 5 stocks. The coverage is on Healthcare, Industrials, Consumer Defensive sectors.

Most recent stock forecast was given on MESO, Mesoblast Ltd at 25-Nov-2025.

Wall Street Analyst David Stanton

Analyst best performing recommendations are on NU (NU HOLDINGS LTD).
The best stock recommendation documented was for NU (NU HOLDINGS LTD) at 6/22/2022. The price target of $3.75 was fulfilled within 8 days with a profit of $0.19 (4.82%) receiving and performance score of 6.03.

Average potential price target upside

MESO Mesoblast Ltd CHE Chemed Corp CSL Carlisle Companies NU Nu Holdings Ltd CL Colgate-Palmolive Company

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Nov-2025

7 months 13 days ago
(25-Nov-2025)

1/2 (50%)

$-5.1 (-75.00%)

527

Buy Since 29-Aug-2024

$24

$10.81 (81.96%)

$15

1 years 5 months 1 days ago
(07-Feb-2025)

4/5 (80%)

$4.51 (23.14%)

69

Hold Since 24-Sep-2024

$12

$-1.19 (-9.02%)

1 years 9 months 14 days ago
(24-Sep-2024)

2/2 (100%)

$4.73 (65.06%)

78

Buy Since 22-Oct-2019

1 years 10 months 9 days ago
(29-Aug-2024)

0/3 (0%)

$30.78 (955.90%)

Sell Since 11-Feb-2021

$3

$-12 (-80.00%)

2 years 11 months 4 days ago
(04-Aug-2023)

5/5 (100%)

$-0.28 (-8.54%)

119

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by David Stanton?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?